ImmunoPrecise Antibodies (IPA) has released an update.
ImmunoPrecise Antibodies Ltd. is set to discuss its first-quarter financial results for fiscal year 2025 and recent business highlights in an earnings conference call on September 16, 2024. The call, which will include a live webcast and a Q&A session, will provide shareholders and interested parties with valuable insights into the company’s performance and future prospects.
For further insights into IPA stock, check out TipRanks’ Stock Analysis page.
